Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...
The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...
Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...
S-ICD defibrillator: implantable device shocks irregular heartbeats to return them to normal rhythm San Clemente-based Cameron Health Inc. last week cleared a regulatory hurdle on the way to its sale ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback